Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Jun 16, 2023 $56.66 $56.85 $54.38 $55.23 1 135 273
Jun 15, 2023 $57.94 $58.03 $55.98 $56.10 750 093
Jun 14, 2023 $58.90 $59.53 $57.81 $58.04 490 661
Jun 13, 2023 $57.70 $59.37 $57.59 $58.77 797 458
Jun 12, 2023 $59.64 $59.98 $57.05 $57.66 601 276
Jun 09, 2023 $57.03 $59.68 $56.46 $59.54 999 484
Jun 08, 2023 $56.34 $56.97 $55.43 $56.70 373 445
Jun 07, 2023 $54.03 $57.02 $53.59 $56.53 785 517
Jun 06, 2023 $52.06 $54.35 $52.06 $53.74 543 534
Jun 05, 2023 $49.57 $52.11 $49.09 $51.93 528 756
Jun 02, 2023 $50.04 $50.24 $48.75 $49.82 373 409
Jun 01, 2023 $49.36 $50.11 $49.00 $49.56 221 822
May 31, 2023 $49.78 $51.03 $48.89 $49.50 414 730
May 30, 2023 $50.91 $51.15 $49.37 $49.60 358 605
May 26, 2023 $50.21 $50.44 $48.89 $50.23 330 378
May 25, 2023 $51.37 $51.37 $48.90 $49.15 507 190
May 24, 2023 $51.81 $52.03 $51.03 $51.64 320 656
May 23, 2023 $53.38 $54.50 $52.01 $52.44 460 247
May 22, 2023 $53.45 $54.26 $53.06 $53.38 262 223
May 19, 2023 $52.99 $54.01 $52.53 $53.03 402 316
May 18, 2023 $52.18 $52.64 $51.05 $52.43 366 705
May 17, 2023 $51.73 $52.85 $50.86 $52.34 355 958
May 16, 2023 $52.09 $52.27 $50.94 $51.48 396 718
May 15, 2023 $52.10 $53.59 $51.22 $53.30 545 966
May 12, 2023 $52.76 $52.96 $51.14 $51.68 388 550
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT